{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:43:33Z","timestamp":1787957013125,"version":"build-2784847793"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The purpose of this study was to evaluate the role of vacuum-assisted biopsy (VAB) in resecting breast cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective database analysis of 116 cancers [both invasive breast cancers (IC) and ductal carcinoma <jats:italic>in situ<\/jats:italic> (DCIS)] diagnosed by VAB submitted to standard surgical treatment with complete histological data from VAB and surgery. Excision following VAB was defined as complete resection (CR) if there was no residual tumor in the surgical specimen, minimal residual disease (MRD) if residual tumor \u2264 3\u00a0mm, gross residual disease (GRD) if residual tumor &amp;gt; 3\u00a0mm, and upgrade from DCIS on VAB to IC. CR and MRD were combined as potentially resected percutaneously (PRP). GRD and those with upgrade to IC were determined not eligible for percutaneous resection (NPR). Factors predictive of PRP were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age was 55.6 years (20\u201391; SD: 12,27). CR was seen in 29 of 116 cases (25%), MRD in 18 of 116 cases (15.5%), GRD in 64 of 116 cases (55.2%), and five of 116 cases (4.3%) were upgraded from DCIS to IC, and those groups combined represented 47 cases of PRP (40.5%) and 69 (59,5%) of NPR. For 77 tumors \u2264 10\u00a0mm, 45 (58.5%) were PRP. Multivariate analysis reveals significance for enlarged VAB (EVAB) (<jats:italic>p<\/jats:italic> = 0.008, OR: 4.4, 95% CI), low\/intermediate nuclear grade (<jats:italic>p<\/jats:italic> &amp;lt; 0.001, OR: 12.5, 95% CI) and final tumor size (T) \u2264 10\u00a0mm (<jats:italic>p<\/jats:italic> = 0.001, OR: 50.1, 95% CI) for PRP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study showed that lesions completely excised with VAB that were cancer could have been treated with VAB rather than surgery but tumor selection in terms of subtype and size is important.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1239574","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:15:16Z","timestamp":1695323716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential role of vacuum-assisted procedures in resecting breast cancers and highlighting selection criteria to support future trials"],"prefix":"10.3389","volume":"13","author":[{"given":"C. N.","family":"Valadares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Toppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2017.11.002","article-title":"Mammography screening: A major issue in medicine","volume":"90","author":"Autier","year":"2018","journal-title":"Eur J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1498","article-title":"Rethinking screening for breast cancer and prostate cancer","volume":"302","author":"Esserman","year":"2009","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1748-z","article-title":"Impact of mammographic screening on the detection of good and poor prognosis breast cancers","volume":"130","author":"Esserman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1613680","article-title":"Are Small Breast Cancers Good because They Are Small or Small because They Are Good","author":"Lannin","year":"2017","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review. Independent UK Panel on Breast Cancer Screening","volume":"380","author":"Marmot","year":"2012","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000377","article-title":"Persistent breast pain among women with histories of breast-conserving surgery for breast cancer compared with women without histories of breast surgery or cancer","volume":"33","author":"Edmond","year":"2017","journal-title":"Clin J Pain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1054\/jpai.2000.7884","article-title":"Mammography pain in women treated conservatively for breast cancer","volume":"1","author":"Kornguth","year":"2000","journal-title":"J Pain"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14063","article-title":"Epidemiology and predictive factors for persistent breast pain following breast-conserving surgery","volume":"13","author":"Monib","year":"2021","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4668-9","article-title":"Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis","volume":"27","author":"Mauri","year":"2017","journal-title":"Eur Radiol"},{"key":"B11","volume-title":"Image-Guided vacuum-assisted excision biopsy of benign breast lesions, Interventional procedures guidance","author":"Dillon","year":"2006"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain Malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder a","year":"2018","journal-title":"Clin Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2021.01.021","article-title":"The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England","author":"Sharma","year":"2021","journal-title":"Clin Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109258","article-title":"Role of vacuum assisted excision in minimising overtreatment of ductal atypias","volume":"131","author":"McMahon","year":"2020","journal-title":"Eur J Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2019.05.008","article-title":"The SMALL trial: A big change for small breast cancers","volume":"31","author":"Morgan","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B16","unstructured":"Brazilian\u2019s guideline for breast cancer diagnose and treatment"},{"key":"B17","volume-title":"TNM classification of Malignant tumours","author":"Brierley","year":"2016"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"B19","unstructured":"Breast cancer Dutch Guideline, version 2.0"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4232-6","article-title":"Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival","volume":"164","author":"Vos","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2019.08.002","article-title":"Involved margins after lumpectomy for breast cancer: Always to be re-excised","volume":"30","author":"Sorrentino","year":"2019","journal-title":"Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2017.06.007","article-title":"Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrence","volume":"43","author":"Vos","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5490-y","article-title":"Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery","volume":"23","author":"Fitzgerald","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2015.01.002","article-title":"Breast cancer screening: an evidence-based update","volume":"99","author":"Fuller","year":"2015","journal-title":"Med Clin North Am"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2016161174","article-title":"National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast-cancer tumor size, overdiagnosis and mammography screening effectiveness","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2017.09.016","article-title":"How do we manage overdiagnosis\/overtreatment in breast screening","volume":"73","author":"Wallis","year":"2018","journal-title":"Clin Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive services task force recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.03.004","article-title":"Thermal ablation as an alternative for surgical resection of small (2 cm) breast cancers: A meta-analysis","volume":"21","author":"van de Voort","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10501-4","article-title":"Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial","volume":"28","author":"Fine","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-020-05814-z","article-title":"Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance","volume":"184","author":"Sanderink","year":"2020","journal-title":"Breast Cancer Res Treat"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1239574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:15:20Z","timestamp":1695323720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1239574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":31,"alternative-id":["10.3389\/fonc.2023.1239574"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1239574","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"article-number":"1239574"}}